We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+7.8%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$484B
AUM Growth
+$29.1B
Cap. Flow
-$16.6B
Cap. Flow %
-3.43%
Top 10 Hldgs %
36.47%
Holding
15,826
New
1,205
Increased
5,575
Reduced
7,223
Closed
1,562

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$545M
2
DXCM icon
DexCom
DXCM
+$457M
3
T icon
AT&T
T
+$431M
4
PANW icon
Palo Alto Networks
PANW
+$416M
5
HUM icon
Humana
HUM
+$394M

Sector Composition

Rank Sector Weight
1 Technology 3.03%
2 Healthcare 2.92%
3 Consumer Discretionary 1.99%
4 Financials 1.93%
5 Industrials 1.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GCMG icon
12376
PUT
GCM Grosvenor
GCMG
$2.81B
$27.1K ﹤0.01%
3,600
+300
+9% +$2.24K
ENLV icon
12377
PUT
Enlivex Ltd
ENLV
$26.6M
$27.1K ﹤0.01%
687
+247
+56% +$10.3K
ALGS icon
12378
Aligos Therapeutics
ALGS
$43M
$27.1K ﹤0.01%
1,114
-2,401
-68% -$64.4K
BCDAW
12379
DELISTED
BioCardia, Inc. Warrant
BCDAW
$27K ﹤0.01%
36,072
+5,115
+17% +$4.46K
ROIC
12380
CALL
DELISTED
Retail Opportunity Investments Corp.
ROIC
$27K ﹤0.01%
2,000
+200
+11% +$2.59K
CYTH
12381
DELISTED
Cyclo Therapeutics, Inc. Common Stock
CYTH
$27K ﹤0.01%
16,979
-1,522
-8% -$1.94K
IVCAW
12382
DELISTED
Investcorp AI Acquisition Corp. Warrant
IVCAW
$27K ﹤0.01%
627,020
-4,523
-0.7% -$196
BCPC
12383
PUT
Balchem Corp
BCPC
$5.69B
$27K ﹤0.01%
200
-100
-33% -$12.9K
GNR icon
12384
CALL
State Street SPDR S&P Global Natural Resources ETF
GNR
$4.93B
$27K ﹤0.01%
500
-2,000
-80% -$110K
LMAT icon
12385
CALL
LeMaitre Vascular
LMAT
$1.88B
$26.9K ﹤0.01%
400
+300
+300% +$18.3K
UONEK icon
12386
Urban One Class D
UONEK
$23.4M
$26.9K ﹤0.01%
449
-1,986
-82% -$113K
HONE
12387
CALL
DELISTED
HarborOne Bancorp
HONE
$26.9K ﹤0.01%
3,100
+2,500
+417% +$23.9K
IFBD icon
12388
Infobird
IFBD
$8.68M
$26.9K ﹤0.01%
137
+116
+552% +$33.1K
PRSU
12389
PUT
Pursuit Attractions and Hospitality Inc
PRSU
$1.31B
$26.9K ﹤0.01%
1,000
-2,800
-74% -$62.2K
BWXT icon
12390
BWX Technologies
BWXT
$15.9B
$26.8K ﹤0.01%
375
-68,992
-99% -$4.51M
AXTI icon
12391
CALL
AXT Inc
AXTI
$5.35B
$26.8K ﹤0.01%
7,800
-9,800
-56% -$33K
MPRAW
12392
DELISTED
Mercato Partners Acquisition Corporation Warrant
MPRAW
$26.8K ﹤0.01%
439,508
-22,092
-5% -$1.47K
SQNS
12393
PUT
Sequans Communications SA
SQNS
$45.3M
$26.8K ﹤0.01%
+480
New +$27.3K
NOAH
12394
CALL
Noah Holdings
NOAH
$592M
$26.8K ﹤0.01%
+1,900
New +$29.7K
RELX icon
12395
PUT
RELX
RELX
$60B
$26.7K ﹤0.01%
800
+600
+300% +$19.3K
JSPR icon
12396
CALL
Jasper Therapeutics
JSPR
$26.3M
$26.7K ﹤0.01%
1,950
+1,300
+200% +$19.3K
DGRW icon
12397
CALL
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$17.3B
$26.7K ﹤0.01%
400
-600
-60% -$38.1K
NVRI icon
12398
PUT
Enviri
NVRI
$579M
$26.6K ﹤0.01%
2,700
+600
+29% +$4.94K
BANC icon
12399
CALL
Banc of California
BANC
$3.13B
$26.6K ﹤0.01%
2,300
-1,600
-41% -$18.5K
SPNS
12400
CALL
DELISTED
Sapiens International
SPNS
$26.6K ﹤0.01%
1,000
-4,100
-80% -$96.7K

Similar funds

Citadel Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Citadel Advisors held 15,826 positions worth $484B, up 6.4% from $455B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Citadel Advisors withdrew a net $16.6B in Q2 2023, closing 1,562 positions and reducing 7,223 holdings. Its most notable exit was State Street Industrial Select Sector SPDR ETF, an estimated $192M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Citadel Advisors opened a new position in BILL Holdings worth $222M.

  • Citadel Advisors's largest Q2 2023 buy was BILL Holdings: 1,901,064 shares worth $222M.
  • Citadel Advisors added most to Microsoft in Q2 2023, an estimated $640M increase.
  • Citadel Advisors's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $545M.
  • Citadel Advisors fully exited State Street Industrial Select Sector SPDR ETF in Q2 2023, selling an estimated $192M.
  • Citadel Advisors's ten largest holdings make up 36% of its $484B portfolio in Q2 2023.
  • Citadel Advisors opened 1,205 new positions and closed 1,562 in Q2 2023.
  • Citadel Advisors's portfolio value rose 6.4% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.